{"meta":{"query_hash":"cbefac99ba71","filters":{"venue":"Cancer Communications"},"cohort_total":24,"direct_labels_cover":0,"predictions_cover":24,"exported":24,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cbefac99ba71","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Communications"},"results":[{"id":"W2978677248","doi":"10.1186/s40880-019-0397-1","title":"A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Colorectal cancer; Stage (stratigraphy); Disease; Cancer; Oncology; Medicine; Internal medicine; Adjuvant; Bioinformatics; Adjuvant chemotherapy; Biomarker; Adjuvant therapy; Biology","score_opus":0.02352228968308826,"score_gpt":0.29569361773845937,"score_spread":0.2721713280553711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978677248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97887427,0.009171375,0.0036984428,0.0016539403,0.00049338536,0.0001628161,0.0023573178,0.00010748901,0.003480869],"genre_scores_gemma":[0.990721,0.001738537,0.0031516752,0.0002757201,0.0004942661,0.0001582168,0.0025334626,0.000012189276,0.00091488997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960834,0.000096550895,0.000060305676,0.000079214544,0.00009647937,0.000059104073],"domain_scores_gemma":[0.9987984,0.0003561418,0.00034403062,0.000057579757,0.00025729326,0.00018663084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009727154,0.00062292,0.0007431988,0.0013901845,0.00046024402,0.0009367491,0.00060050434,0.00089749455,0.0023330662],"category_scores_gemma":[0.00432735,0.00020153805,0.0006700452,0.0011579782,0.00020867208,0.00076899247,0.00062636635,0.0009533069,0.0005843126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006712077,0.00008784468,0.97362995,0.00009259031,0.00011637896,0.0001975582,0.000054699965,0.00044189938,0.00039192665,0.00008693436,0.0019300707,0.022299046],"study_design_scores_gemma":[0.00021324612,0.0009996155,0.9612418,0.00021927731,0.0010171192,0.0024819183,0.00043058358,0.025238719,0.00087905955,0.0010538575,0.0061275586,0.00009725965],"about_ca_topic_score_codex":0.0014651171,"about_ca_topic_score_gemma":0.0027448914,"teacher_disagreement_score":0.0023330662,"about_ca_system_score_codex":0.00033021253,"about_ca_system_score_gemma":0.00058325427,"threshold_uncertainty_score":0.00780493},"labels":[],"label_agreement":null},{"id":"W2979711603","doi":"10.1186/s40880-019-0405-5","title":"Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"Renji Hospital; Science and Technology Commission of Shanghai Municipality; Pfizer","keywords":"Sunitinib; Sorafenib; Axitinib; Medicine; Renal cell carcinoma; Oncology; Targeted therapy; Internal medicine; Neoadjuvant therapy; Radiation therapy; Tyrosine-kinase inhibitor; Cancer; Breast cancer; Hepatocellular carcinoma","score_opus":0.08029438110833828,"score_gpt":0.3685204662015316,"score_spread":0.28822608509319336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979711603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95868546,0.036907654,0.0009762861,0.0003185136,0.00022757908,0.00041121506,0.001483484,0.000015751537,0.0009741438],"genre_scores_gemma":[0.9882265,0.0066411295,0.0010200177,0.00063792604,0.00071402785,0.00027907116,0.0020773697,0.000023620052,0.0003803905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965288,0.0007378797,0.0011305764,0.00071114174,0.0006838869,0.00020765439],"domain_scores_gemma":[0.98997724,0.0036422592,0.0037275946,0.00081562734,0.001154375,0.00068287767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043538515,0.0004275018,0.0018217632,0.0014165774,0.0004919263,0.0011277959,0.0005411998,0.000799197,0.0024856653],"category_scores_gemma":[0.0063216807,0.00045335898,0.0022195852,0.0022206784,0.0006571268,0.0012156616,0.00058900105,0.0009563823,0.000475558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009755284,0.0010169606,0.95505476,0.0016967942,0.00463244,0.0011318723,0.00022841846,0.00021029775,0.0008755711,0.0001450546,0.0012919244,0.02396069],"study_design_scores_gemma":[0.0028658658,0.021335738,0.9290376,0.0009847741,0.015397423,0.010793182,0.0010605367,0.0016212158,0.0014532631,0.00042077975,0.014792696,0.00023701957],"about_ca_topic_score_codex":0.00041587694,"about_ca_topic_score_gemma":0.0006592532,"teacher_disagreement_score":0.0043538515,"about_ca_system_score_codex":0.0005489243,"about_ca_system_score_gemma":0.00069032924,"threshold_uncertainty_score":0.023025632},"labels":[],"label_agreement":null},{"id":"W2981537896","doi":"10.1186/s40880-019-0398-0","title":"Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma","year":2019,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China; Varian Medical Systems; Sanofi; National Key Research and Development Program of China; AstraZeneca","keywords":"Nasopharyngeal carcinoma; Stage (stratigraphy); Chemoradiotherapy; Oncology; DNA sequencing; Chemotherapy; Medicine; Internal medicine; DNA; Biology; Radiation therapy; Genetics","score_opus":0.05932965691010148,"score_gpt":0.32464803823942145,"score_spread":0.26531838132931995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981537896","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924263,0.054205947,0.014864134,0.0011737569,0.000548792,0.0004869975,0.00014023394,0.00015830717,0.004158786],"genre_scores_gemma":[0.98789537,0.005205522,0.005821738,0.00023047585,0.00021566298,0.00018425535,0.00013748594,0.000021275593,0.00028833174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960464,0.00013462531,0.00005948249,0.0000665715,0.0000906467,0.000044091892],"domain_scores_gemma":[0.9996301,0.00010603148,0.00010480868,0.000025181636,0.0000406262,0.00009321379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005882902,0.00031405778,0.0011089768,0.0004662397,0.00019955059,0.00038624654,0.0003040023,0.0002688094,0.00059199095],"category_scores_gemma":[0.002071152,0.00015131525,0.00029752954,0.00030439004,0.00019599772,0.00044415548,0.0002421294,0.0005225724,0.00016448068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014900082,0.002176073,0.091194086,0.00072747335,0.0003467749,0.00041784684,0.000335116,0.022199394,0.039095517,0.0006967147,0.0027802326,0.82513064],"study_design_scores_gemma":[0.004762094,0.051827822,0.67507994,0.0018437703,0.0035541449,0.004645793,0.000872721,0.13102703,0.06499303,0.013172397,0.04790515,0.00031603247],"about_ca_topic_score_codex":0.0006978638,"about_ca_topic_score_gemma":0.0015698703,"teacher_disagreement_score":0.0011089768,"about_ca_system_score_codex":0.0005320376,"about_ca_system_score_gemma":0.0008359194,"threshold_uncertainty_score":0.0038601756},"labels":[],"label_agreement":null},{"id":"W3092210493","doi":"10.1002/cac2.12101","title":"The prognostic significance of non‐sentinel lymph node metastasis in cutaneous and acral melanoma patients—A multicenter retrospective study","year":2020,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brandon Regional Health Authority","funders":"National Natural Science Foundation of China","keywords":"Medicine; Sentinel lymph node; Melanoma; Internal medicine; Oncology; Adjuvant therapy; Proportional hazards model; Retrospective cohort study; Stage (stratigraphy); Lymphovascular invasion; Cancer; Metastasis; Surgery; Breast cancer","score_opus":0.027369894316273815,"score_gpt":0.29415995583142085,"score_spread":0.26679006151514706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092210493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958533,0.00014767106,0.000025006577,0.000008554247,0.0000018890208,0.0000049423224,0.00010447248,9.0518387e-7,0.000121170546],"genre_scores_gemma":[0.9997249,0.000056135388,0.000030277632,0.000007295441,0.000005717548,0.0000063909715,0.00012840895,6.6608465e-7,0.00004011655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996517,0.00008456047,0.000046149657,0.00011154587,0.000054704753,0.000051377574],"domain_scores_gemma":[0.9989415,0.00013813566,0.00052188407,0.000093933,0.00010175095,0.00020282253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006027567,0.00021643052,0.00025259005,0.0005275737,0.0003024124,0.00042219483,0.0002875907,0.000247034,0.0010301061],"category_scores_gemma":[0.0011427467,0.00021214271,0.0002837013,0.0006036197,0.00023789325,0.00035123597,0.00027208895,0.0002632875,0.00017519045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006726249,0.0000119251645,0.9992975,0.0000045022593,0.000014129916,0.00009396692,0.000023498922,0.000009646974,0.00013032362,0.0000038843264,0.00002056134,0.0003228356],"study_design_scores_gemma":[0.000010375683,0.0001277097,0.9981839,0.000004395813,0.000022692764,0.0010682673,0.00016638165,0.00011950535,0.00006271262,0.000010170342,0.0002208411,0.0000029787673],"about_ca_topic_score_codex":0.001423723,"about_ca_topic_score_gemma":0.0018719219,"teacher_disagreement_score":0.001423723,"about_ca_system_score_codex":0.00022235975,"about_ca_system_score_gemma":0.00021814948,"threshold_uncertainty_score":0.0034461021},"labels":[],"label_agreement":null},{"id":"W3119084223","doi":"10.1002/cac2.12128","title":"Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Ceritinib; Lung cancer; Medicine; ALK inhibitor; ROS1; Adenocarcinoma; Alectinib; Targeted therapy; Internal medicine; Oncology; Cancer research; Pathology; Cancer; Malignant pleural effusion","score_opus":0.04499332222414623,"score_gpt":0.37927840711824706,"score_spread":0.3342850848941008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119084223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47779566,0.10940617,0.0050706533,0.31504884,0.07447542,0.000308762,0.0027902052,0.00048013797,0.014624087],"genre_scores_gemma":[0.82309026,0.02988938,0.0023103128,0.042664118,0.09427033,0.00008578149,0.0008728584,0.00008293043,0.006734008],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999616,0.0000774358,0.000074030824,0.000073800176,0.00009394776,0.00006481292],"domain_scores_gemma":[0.99851817,0.0005567733,0.00025818843,0.000058679354,0.00033984968,0.00026832684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007834313,0.00037292877,0.0008138085,0.0005468136,0.0004623241,0.0008007502,0.0006079974,0.0020433753,0.0020968267],"category_scores_gemma":[0.0034452525,0.0002360802,0.0003404889,0.00043104438,0.0004482045,0.0013552449,0.00042604053,0.0021732955,0.00073616224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029283238,0.00034045803,0.23884751,0.0012632348,0.0003398224,0.27521366,0.0010700229,0.0004661091,0.006167312,0.0015078486,0.35444826,0.1174074],"study_design_scores_gemma":[0.00043390272,0.0010926111,0.17723519,0.0009953006,0.0006167892,0.472638,0.0017453999,0.0043425085,0.0039335145,0.0017575364,0.3349799,0.00022931812],"about_ca_topic_score_codex":0.00036300163,"about_ca_topic_score_gemma":0.000657502,"teacher_disagreement_score":0.0020968267,"about_ca_system_score_codex":0.00023094141,"about_ca_system_score_gemma":0.00022900352,"threshold_uncertainty_score":0.0070145726},"labels":[],"label_agreement":null},{"id":"W3133444826","doi":"10.1002/cac2.12151","title":"An integrated genetic‐epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID‐19) and cancer","year":2021,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Genome British Columbia; University of British Columbia","funders":"","keywords":"Biostatistics; Library science; Columbia university; Epidemiology; Medicine; History; Geography; Sociology; Media studies; Pathology","score_opus":0.1737411189530755,"score_gpt":0.4479511603154512,"score_spread":0.2742100413623757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133444826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9270184,0.025220083,0.028132059,0.0018152784,0.00049791095,0.00022059945,0.0077546034,0.00046591248,0.008875076],"genre_scores_gemma":[0.96594787,0.010264011,0.013563732,0.0014129048,0.00020270229,0.00015180673,0.004060151,0.000083252104,0.004313654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999788,0.00001636763,0.00001321253,0.000078674166,0.00005683091,0.000046890716],"domain_scores_gemma":[0.9998332,0.000024508085,0.000054896,0.000021869739,0.000033659275,0.000031752195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028650614,0.00030423395,0.00034175592,0.00067824026,0.0004979928,0.00048616616,0.00026979024,0.00050255965,0.0027388155],"category_scores_gemma":[0.00041076945,0.0001639869,0.0005065929,0.00047786415,0.00039557385,0.00039188223,0.00060524244,0.0008275325,0.00034102655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005246847,0.00021219932,0.09277011,0.00090349815,0.00029762927,0.001791895,0.0004088369,0.0009188634,0.8027065,0.005335054,0.003616208,0.09051457],"study_design_scores_gemma":[0.00012476937,0.0016462208,0.5614136,0.00032671797,0.0010984088,0.012700948,0.0007604734,0.006927158,0.31796932,0.0068885735,0.08999219,0.00015167],"about_ca_topic_score_codex":0.0012982573,"about_ca_topic_score_gemma":0.0029494364,"teacher_disagreement_score":0.0027388155,"about_ca_system_score_codex":0.00037417444,"about_ca_system_score_gemma":0.0005075862,"threshold_uncertainty_score":0.009162188},"labels":[],"label_agreement":null},{"id":"W3199261654","doi":"10.1002/cac2.12205","title":"Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Institute on Aging; Swedish Cancer Foundation; Medical Research Council; Canadian Institutes of Health Research; Ovarian Cancer Research Fund; National Institutes of Health; National Heart, Lung, and Blood Institute; Vetenskapsrådet; National Health and Medical Research Council; Cancer Research UK; Wellcome Trust; European Commission; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"DNA methylation; Prostate cancer; Computational biology; Biobank; Bioinformatics; Computer science; Oncology; Medicine; Biology; Cancer; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.09813911593421933,"score_gpt":0.3754635667036976,"score_spread":0.2773244507694783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199261654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80022156,0.0013871446,0.1953637,0.0005670819,0.000051417945,0.00028978713,0.0010466469,0.00048718345,0.00058543246],"genre_scores_gemma":[0.8538071,0.00026778376,0.14144161,0.00025201388,0.000053501815,0.00026233177,0.0033807694,0.00009271028,0.0004420973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837166,0.0010491334,0.00006300092,0.00029309816,0.00016241836,0.000060769267],"domain_scores_gemma":[0.9967468,0.0020070313,0.0002763586,0.0003518278,0.00042998532,0.00018793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007864155,0.0009255899,0.0011928576,0.0009437577,0.00043164447,0.0007186469,0.0012583691,0.00079812657,0.00074897805],"category_scores_gemma":[0.0072106104,0.00046267058,0.0017411768,0.0008278287,0.00032594134,0.0005464113,0.0012844164,0.0012887832,0.00015379363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030919558,0.0013611944,0.3707751,0.0005944007,0.0038319207,0.00077752915,0.00048295202,0.3188903,0.03946892,0.0020698688,0.004200382,0.2544554],"study_design_scores_gemma":[0.0003209038,0.0010808154,0.04607281,0.000028076212,0.0007373942,0.000380631,0.0000773206,0.9418568,0.006188297,0.001876076,0.0013378805,0.000042989897],"about_ca_topic_score_codex":0.0042226436,"about_ca_topic_score_gemma":0.004110466,"teacher_disagreement_score":0.007864155,"about_ca_system_score_codex":0.00047418597,"about_ca_system_score_gemma":0.0011004905,"threshold_uncertainty_score":0.041590154},"labels":[],"label_agreement":null},{"id":"W3207609899","doi":"10.1002/cac2.12223","title":"Licochalcone A suppresses Sp1 expression with potential anti‐myeloma activity","year":2021,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Multiple myeloma; Cancer research; Expression (computer science); Chemistry; Biology; Medicine; Internal medicine; Computer science","score_opus":0.18194061755284416,"score_gpt":0.46442200016496105,"score_spread":0.28248138261211686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207609899","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073541054,0.11632585,0.0018621162,0.28798586,0.5811015,0.00009763613,0.00064346625,0.00025219563,0.004377282],"genre_scores_gemma":[0.0431058,0.06506146,0.0013565186,0.16298336,0.70699614,0.0001387776,0.00036283373,0.00013655415,0.019858653],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990465,0.0001696276,0.00017719086,0.00015880469,0.00034980857,0.00009805829],"domain_scores_gemma":[0.9969463,0.0013188,0.0004867741,0.000087923814,0.00079644745,0.00036368953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021210387,0.00061817287,0.0010594442,0.0005060095,0.0004637197,0.0017434359,0.0014126115,0.0035145148,0.0042107888],"category_scores_gemma":[0.005350872,0.00037441673,0.000492787,0.00033245562,0.0011089509,0.0013657407,0.0007101416,0.0063056042,0.0026927434],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016570252,0.0001502575,0.0010824344,0.0038023943,0.00013641443,0.0034008576,0.00016587098,0.00015599176,0.011261863,0.00252008,0.8721354,0.10353147],"study_design_scores_gemma":[0.00017173713,0.00030699922,0.0016481554,0.00036537653,0.0001241113,0.0037657472,0.00011512942,0.0004747262,0.005494839,0.0009704921,0.9865253,0.000037371887],"about_ca_topic_score_codex":0.00019473162,"about_ca_topic_score_gemma":0.00037974096,"teacher_disagreement_score":0.0042107888,"about_ca_system_score_codex":0.0005880318,"about_ca_system_score_gemma":0.00065514696,"threshold_uncertainty_score":0.0140865445},"labels":[],"label_agreement":null},{"id":"W3208045032","doi":"10.1002/cac2.12218","title":"The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Clinical Oncology; Internal medicine; Oncology; Incidence (geometry); Medical physics; Intensive care medicine; Radiation therapy; Cancer","score_opus":0.4629509190193338,"score_gpt":0.5729864008573355,"score_spread":0.11003548183800177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208045032","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011716003,0.3874787,0.04663663,0.23969528,0.0320406,0.015046328,0.02347669,0.0015428497,0.2423669],"genre_scores_gemma":[0.08329042,0.46725202,0.2079543,0.07207655,0.009093883,0.021737825,0.07034399,0.000518113,0.06773295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99203426,0.00268098,0.0020759825,0.00022584652,0.002437423,0.00054551],"domain_scores_gemma":[0.9787228,0.0027259318,0.0016239046,0.0005596879,0.015424621,0.0009430375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007710456,0.0011104357,0.001777497,0.0072007114,0.0018677419,0.0018402193,0.0027993307,0.0028302113,0.0058531673],"category_scores_gemma":[0.020137094,0.00054274674,0.0019140298,0.0060140532,0.001485153,0.0010840492,0.0020331289,0.0038683766,0.0027402171],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000907263,0.000106036714,0.0036801104,0.0037618454,0.00014901655,0.0005083563,0.00042663535,0.0010636797,0.0008504228,0.006875955,0.7427378,0.23974943],"study_design_scores_gemma":[0.00009272044,0.00007350216,0.008791799,0.0052150125,0.00017596436,0.0008694813,0.00028030644,0.0005272652,0.00034019965,0.0030019342,0.9805689,0.00006299949],"about_ca_topic_score_codex":0.05351391,"about_ca_topic_score_gemma":0.09232449,"teacher_disagreement_score":0.05351391,"about_ca_system_score_codex":0.005188551,"about_ca_system_score_gemma":0.038243927,"threshold_uncertainty_score":0.10640484},"labels":[],"label_agreement":null},{"id":"W3214235689","doi":"10.1002/cac2.12236","title":"Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows","year":2021,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health","keywords":"Indocyanine green; Pancreatic cancer; Infrared; Fluorescence; Fluorescence-lifetime imaging microscopy; Medicine; Nuclear medicine; Cancer; Chemistry; Pathology; Optics; Internal medicine; Physics","score_opus":0.01768173778084683,"score_gpt":0.23741186773626835,"score_spread":0.21973012995542152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214235689","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010192668,0.17950073,0.012241937,0.22846125,0.5599837,0.000110716144,0.00027712248,0.00040199293,0.008829907],"genre_scores_gemma":[0.06645558,0.1269486,0.0069664554,0.105777115,0.66868544,0.000117766474,0.00021673752,0.00025413843,0.024578111],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991749,0.00019670554,0.0001195078,0.00014786997,0.0002949866,0.00006595644],"domain_scores_gemma":[0.99653095,0.0015917465,0.00042313922,0.00010265973,0.0010757088,0.0002758696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002041999,0.00047841127,0.00077796215,0.0007562505,0.00033770566,0.0014735627,0.0012009032,0.002907519,0.003163754],"category_scores_gemma":[0.0058081406,0.00035022802,0.00048968906,0.0004298724,0.0015805012,0.0019468247,0.00037226916,0.004735081,0.002876352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011045441,0.000077046505,0.0034666068,0.0029548933,0.00012207495,0.006740546,0.00019569421,0.00020275486,0.009820516,0.003873591,0.74847806,0.22296374],"study_design_scores_gemma":[0.00006924931,0.00020260064,0.0022959677,0.00060266466,0.00011923985,0.018281106,0.0001493969,0.0011252087,0.0065578977,0.0011650793,0.96937627,0.000055367494],"about_ca_topic_score_codex":0.00031229472,"about_ca_topic_score_gemma":0.0005056158,"teacher_disagreement_score":0.003163754,"about_ca_system_score_codex":0.00063527876,"about_ca_system_score_gemma":0.00046790307,"threshold_uncertainty_score":0.010799229},"labels":[],"label_agreement":null},{"id":"W4281746720","doi":"10.1002/cac2.12314","title":"Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study","year":2022,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Association of University Research Administrators","funders":"Deutsche Forschungsgemeinschaft","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Retrospective cohort study; Incidence (geometry); Quarter (Canadian coin); Cancer; Medicine; 2019-20 coronavirus outbreak; Cohort; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Register (sociolinguistics); Cancer incidence; Internal medicine; Virology; Disease; History; Mathematics","score_opus":0.15244275992520911,"score_gpt":0.4369747190569758,"score_spread":0.2845319591317667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281746720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506,0.003708137,0.00032860137,0.00023637073,0.00007116296,0.000047754093,0.009813318,0.000020079135,0.00071471033],"genre_scores_gemma":[0.9947296,0.00083046436,0.00015554998,0.00010418572,0.000063514344,0.000047731457,0.0038555227,0.000011764625,0.00020160306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984816,0.00022482271,0.00027186456,0.0005646601,0.00020766204,0.0002494032],"domain_scores_gemma":[0.9975376,0.0003616954,0.0012783319,0.00041879783,0.00018871766,0.00021481501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013764763,0.00039123665,0.00086354074,0.001837646,0.00055304763,0.0011419599,0.000789574,0.00074490585,0.0027734714],"category_scores_gemma":[0.0035900837,0.0007268487,0.0011337455,0.003352193,0.00032665403,0.0010676715,0.00078435533,0.0008477968,0.0007447202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019234905,0.00003022803,0.9964371,0.000075829,0.00032964698,0.00012765349,0.00009770969,0.000039325234,0.000077052,0.00005364547,0.0010352923,0.0015041301],"study_design_scores_gemma":[0.000024155232,0.0000624988,0.9977591,0.000054853797,0.00022991533,0.00037936412,0.00018964733,0.00023901596,0.000045588164,0.000046329882,0.0009563991,0.000013208612],"about_ca_topic_score_codex":0.006951049,"about_ca_topic_score_gemma":0.009253711,"teacher_disagreement_score":0.006951049,"about_ca_system_score_codex":0.00050841866,"about_ca_system_score_gemma":0.00050822046,"threshold_uncertainty_score":0.013821125},"labels":[],"label_agreement":null},{"id":"W4308187251","doi":"10.1002/cac2.12383","title":"Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy","year":2022,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Science and Technology Commission of Shanghai Municipality; Shanghai Pulmonary Hospital; National Natural Science Foundation of China","keywords":"Chemotherapy; Oncology; Lung cancer; Medicine; Immune system; Immunotherapy; Internal medicine; CD68; Predictive marker; PD-L1; CD8; Blockade; Immune checkpoint; Cancer research; Cancer; Immunology; Immunohistochemistry; Receptor","score_opus":0.014554368802750031,"score_gpt":0.2962930912548511,"score_spread":0.2817387224521011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308187251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991068,0.0003124438,0.00036529702,0.000008021829,0.0000013619906,0.0000057551224,0.00004117905,0.000012925078,0.00014618592],"genre_scores_gemma":[0.9992706,0.00007925941,0.00046149603,0.000006632493,0.0000022742604,0.000010158331,0.00005493616,9.914911e-7,0.00011358865],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993086,0.000016486942,0.0000032360913,0.000017882552,0.000014834491,0.000016781009],"domain_scores_gemma":[0.99989784,0.00002960832,0.00003746878,0.0000050554063,0.000011911273,0.000018141887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015222363,0.00012206304,0.00016386546,0.00027808742,0.00007073722,0.00018049034,0.00008828575,0.00016175713,0.00058232056],"category_scores_gemma":[0.00025533926,0.00008517187,0.00008291754,0.00011430895,0.000085698644,0.00012596366,0.00008264456,0.0001880612,0.000102211605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024941303,0.00014931809,0.25193512,0.00007489726,0.000040442206,0.00025160614,0.00012673331,0.0006040117,0.72250223,0.000047458456,0.00015554694,0.021618452],"study_design_scores_gemma":[0.00004603766,0.001576642,0.78045505,0.000010015387,0.00008717255,0.001568019,0.00018189417,0.007887804,0.20749483,0.00007487117,0.00060639833,0.000011251134],"about_ca_topic_score_codex":0.00029763082,"about_ca_topic_score_gemma":0.00059485517,"teacher_disagreement_score":0.00058232056,"about_ca_system_score_codex":0.000147717,"about_ca_system_score_gemma":0.000047155474,"threshold_uncertainty_score":0.001947999},"labels":[],"label_agreement":null},{"id":"W4317830464","doi":"10.1002/cac2.12401","title":"A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer","year":2023,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; FujiFilm VisualSonics (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cancer research; Epidermal growth factor receptor; Lung cancer; Population; Receptor tyrosine kinase; Drug resistance; AXL receptor tyrosine kinase; Medicine; Cancer; Chemistry; Pharmacology; Biology; Internal medicine; Receptor","score_opus":0.06163173093804817,"score_gpt":0.38704525461997497,"score_spread":0.3254135236819268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317830464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78409755,0.059288293,0.13498008,0.0024661897,0.0007187858,0.00071689975,0.0009452389,0.0010641399,0.015722822],"genre_scores_gemma":[0.94939053,0.011228595,0.030117374,0.0008931724,0.000089601985,0.0003770217,0.00031821904,0.000048087666,0.0075374506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999473,0.0000054002576,0.0000025296936,0.000015614693,0.000017195633,0.000011994279],"domain_scores_gemma":[0.9999802,0.0000030243814,0.000006931208,0.0000017156484,0.000003182212,0.0000048825596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007487792,0.0004317385,0.00022759347,0.0002572722,0.00013178399,0.00024362022,0.0002760597,0.00046848055,0.0008111336],"category_scores_gemma":[0.000051142422,0.00013394891,0.00021596157,0.00013010041,0.00015160178,0.00031288894,0.00021387184,0.00054365414,0.00041231577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034126206,0.000062963205,0.000050469807,0.000115036644,0.0000071857526,0.000061854655,0.000016212196,0.0003812949,0.9854079,0.0006163425,0.0003072888,0.012939187],"study_design_scores_gemma":[0.00008270983,0.0012911098,0.00095281214,0.000030105355,0.000049482016,0.0007689017,0.000023059958,0.006725538,0.95727026,0.00034459634,0.032438375,0.000023006733],"about_ca_topic_score_codex":0.0003012102,"about_ca_topic_score_gemma":0.00064525893,"teacher_disagreement_score":0.0008111336,"about_ca_system_score_codex":0.00035125506,"about_ca_system_score_gemma":0.00014705479,"threshold_uncertainty_score":0.0027135015},"labels":[],"label_agreement":null},{"id":"W4379507891","doi":"10.1002/cac2.12447","title":"Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer","year":2023,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Ligue Contre le Cancer","keywords":"Oncology; Medicine; Internal medicine; Breast cancer; Pembrolizumab; Cancer; Predictive marker; Immunotherapy; Gene signature; Biology; Gene expression","score_opus":0.015106574438103298,"score_gpt":0.30304266497191407,"score_spread":0.28793609053381075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379507891","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18109682,0.1317454,0.0063979113,0.45819893,0.21250984,0.00021834714,0.0033134713,0.00029482556,0.00622446],"genre_scores_gemma":[0.5064526,0.036764696,0.004263127,0.08261821,0.35786664,0.00016245568,0.0014194272,0.00020771632,0.010245171],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9994678,0.00014657942,0.00010552536,0.00010420488,0.000109516994,0.00006633926],"domain_scores_gemma":[0.99616903,0.0019966422,0.0005112856,0.00013585987,0.00083915633,0.00034814767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020770114,0.00029489218,0.00082250393,0.00059445674,0.0002907313,0.0010478451,0.00062907476,0.0015763906,0.0025378354],"category_scores_gemma":[0.008178266,0.0001524594,0.00030969002,0.00034970805,0.0006502725,0.00079416827,0.00037549174,0.002261123,0.0009650697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066203345,0.0003031523,0.10446757,0.0027338562,0.00042151797,0.009148005,0.00036997907,0.0006171289,0.012360858,0.0018539188,0.6211631,0.23994064],"study_design_scores_gemma":[0.0006376808,0.0014036017,0.13760594,0.0013060436,0.0013612863,0.04417716,0.0009267854,0.011533525,0.013411705,0.0051160795,0.7823069,0.00021333207],"about_ca_topic_score_codex":0.0001860671,"about_ca_topic_score_gemma":0.00032155824,"teacher_disagreement_score":0.0025378354,"about_ca_system_score_codex":0.00026286865,"about_ca_system_score_gemma":0.0003009645,"threshold_uncertainty_score":0.010984421},"labels":[],"label_agreement":null},{"id":"W4387930994","doi":"10.1002/cac2.12496","title":"Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy","year":2023,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Immunophenotyping; Immune system; Cancer research; Biology; KRAS; CD8; Tumor microenvironment; CD80; Immunotherapy; Pancreatic cancer; Flow cytometry; Cancer; Immunology; Cytotoxic T cell; Colorectal cancer","score_opus":0.04858681729706475,"score_gpt":0.3398288874732581,"score_spread":0.29124207017619336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387930994","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484056,0.00068691163,0.0024267747,0.000075760225,0.000026083168,0.00002749189,0.000588998,0.0001027611,0.0012247305],"genre_scores_gemma":[0.99306256,0.0005453167,0.0019285112,0.00005091165,0.000009732415,0.00009086228,0.0005603391,0.000049639977,0.0037021958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970067,0.00003445344,0.00003153116,0.000081088336,0.00006757999,0.00008464709],"domain_scores_gemma":[0.9996761,0.000031713258,0.00012473493,0.00003811787,0.000022689657,0.00010666611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021496437,0.00038316354,0.0002467593,0.0006050135,0.00013721338,0.00044623305,0.00017172948,0.0004328724,0.0015535139],"category_scores_gemma":[0.0001531655,0.00028836276,0.00029022698,0.00018729384,0.00029692735,0.00042147905,0.00021529749,0.0013487944,0.00046384742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042070256,0.000057294365,0.0008641469,0.000019075776,0.0000053057165,0.000036387202,0.00003051806,0.00010824843,0.9972886,0.00009432588,0.00003933749,0.0010360214],"study_design_scores_gemma":[0.000037232738,0.0008277521,0.017416991,0.000011735572,0.000029310726,0.00038406192,0.000086135544,0.0026702285,0.9760568,0.00013002532,0.0023390467,0.000010640494],"about_ca_topic_score_codex":0.00026346027,"about_ca_topic_score_gemma":0.0005253447,"teacher_disagreement_score":0.0015535139,"about_ca_system_score_codex":0.00034186494,"about_ca_system_score_gemma":0.00015003355,"threshold_uncertainty_score":0.0051969886},"labels":[],"label_agreement":null},{"id":"W4393231250","doi":"10.1002/cac2.12540","title":"Immune cell pair ratio captured by imaging mass cytometry has superior predictive value for prognosis of non‐small cell lung cancer than cell fraction and density","year":2024,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Mass cytometry; Lung cancer; Predictive value; Immune system; Cell; Flow cytometry; Medicine; Oncology; Pathology; Internal medicine; Chemistry; Immunology; Phenotype","score_opus":0.01658592197096139,"score_gpt":0.2655287443334488,"score_spread":0.2489428223624874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393231250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539014,0.010595886,0.03006712,0.00073843735,0.00021202453,0.00008389224,0.0012705341,0.00077103806,0.0023597295],"genre_scores_gemma":[0.98659605,0.001118361,0.010287548,0.00024258049,0.00014878795,0.000047998037,0.00092606386,0.00002622609,0.0006062908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968314,0.000054419037,0.000022847893,0.00012999833,0.00008061303,0.000029070217],"domain_scores_gemma":[0.9991615,0.000291613,0.00018654102,0.000086457505,0.00019413703,0.00007983341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001215748,0.00056572416,0.00071197667,0.0017483891,0.00021520923,0.0010563511,0.00044603256,0.00093910116,0.0009570773],"category_scores_gemma":[0.0022690974,0.00022065705,0.000389813,0.0007298562,0.0002858892,0.0005231293,0.00041065435,0.0006654305,0.00039773388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012925058,0.00021079756,0.7993142,0.00024827934,0.00034005317,0.00019097407,0.00012341424,0.0044612247,0.0695892,0.00058865175,0.0026113954,0.121029355],"study_design_scores_gemma":[0.00010863299,0.0007307494,0.64061517,0.00012817208,0.0009961795,0.0018027338,0.00033754547,0.2683798,0.07721841,0.0032323287,0.0062851124,0.00016521577],"about_ca_topic_score_codex":0.0013792384,"about_ca_topic_score_gemma":0.0015375006,"teacher_disagreement_score":0.0017483891,"about_ca_system_score_codex":0.00040672798,"about_ca_system_score_gemma":0.00021079661,"threshold_uncertainty_score":0.006429553},"labels":[],"label_agreement":null},{"id":"W4396900273","doi":"10.1002/cac2.12547","title":"Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Apatinib; Medicine; Oncology; Cervical cancer; Internal medicine; Overall survival; Cancer","score_opus":0.03813081594581162,"score_gpt":0.3588766162722905,"score_spread":0.32074580032647887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396900273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958133,0.0023715654,0.0001160842,0.00019092725,0.000021760194,0.00012229147,0.00076221046,0.0000059825074,0.00059577264],"genre_scores_gemma":[0.9968736,0.0004901386,0.00012315415,0.00018047792,0.000044007927,0.00014262716,0.0019064177,0.0000031792401,0.0002363136],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993018,0.0002638847,0.000061578634,0.00013744606,0.00013043359,0.00010481584],"domain_scores_gemma":[0.9985197,0.00021463702,0.00049787376,0.00009689379,0.00013564396,0.00053519453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026302214,0.00035810895,0.0006978635,0.00032842392,0.0003630326,0.0010140346,0.0004110975,0.00070681766,0.00069911196],"category_scores_gemma":[0.0018408465,0.00019500773,0.00091734325,0.00046162194,0.00031062472,0.0007382452,0.0004733864,0.0014209104,0.00017107674],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14894637,0.004419041,0.75591695,0.00050618115,0.0031950837,0.0006932672,0.00040840186,0.0025528586,0.0070766686,0.00015281244,0.004403282,0.07172907],"study_design_scores_gemma":[0.019630194,0.068699755,0.89802927,0.00013511762,0.00209261,0.0012609059,0.00018690295,0.0023405075,0.00214506,0.00021309333,0.005201624,0.00006497969],"about_ca_topic_score_codex":0.0006612155,"about_ca_topic_score_gemma":0.0014560728,"teacher_disagreement_score":0.0026302214,"about_ca_system_score_codex":0.0008321504,"about_ca_system_score_gemma":0.00095065386,"threshold_uncertainty_score":0.013910115},"labels":[],"label_agreement":null},{"id":"W4402131379","doi":"10.1002/cac2.12604","title":"Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Engineering Link (Canada)","funders":"Wu Jieping Medical Foundation; National Natural Science Foundation of China","keywords":"Medicine; Interim analysis; Internal medicine; Clinical endpoint; Hazard ratio; Oncology; Chemotherapy; Neoadjuvant therapy; Perioperative; Esophageal cancer; Adverse effect; Randomized controlled trial; Cancer; Surgery; Confidence interval; Breast cancer","score_opus":0.10681879480942565,"score_gpt":0.512525384030229,"score_spread":0.4057065892208033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402131379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805493,0.0059473584,0.0010938381,0.0005887422,0.0004691103,0.0016797396,0.0009450927,0.00007326441,0.0011478263],"genre_scores_gemma":[0.9910721,0.0014457217,0.0016892393,0.00059027056,0.00030773605,0.0028079648,0.0013584485,0.00001943646,0.000708939],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980299,0.0013241785,0.00012952468,0.00020947159,0.00010851874,0.00019842778],"domain_scores_gemma":[0.9969971,0.0010216534,0.0009164996,0.00038122115,0.00016879746,0.00051475846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069467425,0.0012563732,0.0027875924,0.000294002,0.00035530375,0.0012053783,0.0007753323,0.0010556661,0.0028197272],"category_scores_gemma":[0.0038981189,0.00045255563,0.0038872838,0.00042864113,0.0007848043,0.0010040317,0.00048487057,0.0023731897,0.00051004713],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97700137,0.003930875,0.0037111724,0.00027947556,0.002814021,0.000024901829,0.00002444915,0.000574354,0.0009048417,0.00005107005,0.00044091084,0.010242578],"study_design_scores_gemma":[0.6366167,0.326991,0.020462556,0.0001245027,0.009390977,0.00011316289,0.000052214753,0.0022689784,0.0018879503,0.00036765935,0.0016806142,0.000043649783],"about_ca_topic_score_codex":0.00016985247,"about_ca_topic_score_gemma":0.0003641062,"teacher_disagreement_score":0.0069467425,"about_ca_system_score_codex":0.00064574525,"about_ca_system_score_gemma":0.0013527116,"threshold_uncertainty_score":0.036738336},"labels":[],"label_agreement":null},{"id":"W4404133614","doi":"10.1002/cac2.12624","title":"FOXO1 or not FOXO1: that is the question","year":2024,"lang":"en","type":"article","venue":"Cancer Communications","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Ligue Contre le Cancer; Bristol-Myers Squibb","keywords":"FOXO1; Cytotoxic T cell; Granzyme B; Biology; Cell biology; Transcription factor; Cancer research; Chemistry; In vitro; Biochemistry; Gene","score_opus":0.20355240978209913,"score_gpt":0.4773397007046023,"score_spread":0.2737872909225032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404133614","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0262862,0.5476633,0.005752996,0.3879641,0.015502986,0.000035381414,0.0022424045,0.000307498,0.014245119],"genre_scores_gemma":[0.26370043,0.5293312,0.003313212,0.14692464,0.028243637,0.00012972417,0.001791002,0.00026173634,0.026304455],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.999199,0.000092691815,0.00004950725,0.0003188155,0.00013414118,0.00020582057],"domain_scores_gemma":[0.99808705,0.00053396204,0.00029979565,0.00014168935,0.00046713164,0.00047038478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026798295,0.0006174919,0.0018751383,0.00050062785,0.000954522,0.0023178204,0.0013502062,0.0035745762,0.008287341],"category_scores_gemma":[0.0026446145,0.0003061307,0.0005690446,0.0007319786,0.005127948,0.005458195,0.001378719,0.004380731,0.003501182],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023081596,0.0003557431,0.01358234,0.008403336,0.0005317415,0.0012692864,0.0015082603,0.00060725823,0.03695625,0.13199314,0.31396347,0.48852104],"study_design_scores_gemma":[0.00016675881,0.0005014111,0.009005895,0.0024405129,0.00019853645,0.0016686206,0.0030220621,0.0005262808,0.0057296488,0.13041115,0.8461887,0.00014041924],"about_ca_topic_score_codex":0.001316675,"about_ca_topic_score_gemma":0.0014567496,"teacher_disagreement_score":0.008287341,"about_ca_system_score_codex":0.0012813873,"about_ca_system_score_gemma":0.0017347273,"threshold_uncertainty_score":0.027723908},"labels":[],"label_agreement":null},{"id":"W4404666579","doi":"10.1002/cac2.12632","title":"PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer","year":2024,"lang":"en","type":"letter","venue":"Cancer Communications","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Breakthrough Breast Cancer","keywords":"Trastuzumab; Breast cancer; Biomarker; Oncology; Internal medicine; Acquired resistance; Medicine; Cancer; Cancer research; Chemistry; Biochemistry","score_opus":0.015404052190529273,"score_gpt":0.2892659662646147,"score_spread":0.27386191407408544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404666579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487054,0.003061196,0.00062236766,0.00006105741,0.000019771693,0.000019263169,0.0006031196,0.00002072629,0.00072191993],"genre_scores_gemma":[0.99757284,0.00073813903,0.00035411384,0.000039150913,0.00001195576,0.000026814656,0.00056657917,0.0000053194512,0.0006850919],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997613,0.000023904504,0.000019938972,0.00006438859,0.00008011096,0.000050456445],"domain_scores_gemma":[0.999908,0.000011440991,0.00004063385,0.0000060240704,0.0000147037135,0.000019254978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021353421,0.00014483627,0.00022696804,0.0002294647,0.00012593028,0.00026404922,0.000098435055,0.00023711903,0.0012316504],"category_scores_gemma":[0.00023855967,0.00009300738,0.00015380741,0.0003609985,0.00014200035,0.00019086285,0.00016441826,0.00041173407,0.00029934567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016264733,0.000114897775,0.023651594,0.0001355722,0.000038218826,0.00045008477,0.00008996182,0.00027635688,0.96246475,0.000061459185,0.000362224,0.010728373],"study_design_scores_gemma":[0.000062104744,0.00089213316,0.60706383,0.000028705155,0.00008909848,0.0027283228,0.00014178845,0.0032583135,0.38049117,0.0001740469,0.0050537027,0.000016810143],"about_ca_topic_score_codex":0.0005808652,"about_ca_topic_score_gemma":0.00076059083,"teacher_disagreement_score":0.0012316504,"about_ca_system_score_codex":0.00033605486,"about_ca_system_score_gemma":0.00010517191,"threshold_uncertainty_score":0.0041202307},"labels":[],"label_agreement":null},{"id":"W4406030350","doi":"10.1002/cac2.12650","title":"A strong internal promoter drives massive expression of YEATS‐domain devoid <i>MLLT3</i> transcripts in HSC and most lethal AML","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut National Du Cancer; Association Laurette Fugain; Ministère de la Santé; Fondation ARC pour la Recherche sur le Cancer; Fondation de France; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"RNA polymerase II; Transcription factor; Transactivation; Molecular biology; Cell biology; Transcription (linguistics); Biology; Chemistry; Promoter; Gene expression; Genetics; Gene","score_opus":0.03057785634176597,"score_gpt":0.3543113829083722,"score_spread":0.32373352656660626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406030350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057956,0.0010735339,0.008455404,0.0003730187,0.000114195595,0.00017788369,0.003346597,0.0011399642,0.004739785],"genre_scores_gemma":[0.9921193,0.00023708407,0.00220548,0.000089954956,0.000031727453,0.0000536053,0.00142658,0.0001912604,0.0036450021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997261,0.000035889978,0.000035278103,0.000054390555,0.00008836191,0.000059992446],"domain_scores_gemma":[0.99972385,0.00004643068,0.00008406387,0.000031525993,0.0000124413755,0.000101733196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000188683,0.00043574543,0.00029355357,0.00037922707,0.000269199,0.0005450306,0.0003268933,0.00038677035,0.003147077],"category_scores_gemma":[0.00016899161,0.00024114677,0.0002829223,0.0003261048,0.00064528664,0.00014865892,0.0004485212,0.0011242935,0.0014653829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007829742,0.000025478352,0.00015134597,0.00001830744,0.000003904926,0.0001171917,0.000024318777,0.00012389023,0.9980414,0.0004042352,0.00019192998,0.0008195777],"study_design_scores_gemma":[0.00006252156,0.00019326936,0.005258062,0.00001504455,0.000022334118,0.0010366801,0.000062915366,0.0024250902,0.9805697,0.00018906975,0.010152516,0.000012820072],"about_ca_topic_score_codex":0.000796752,"about_ca_topic_score_gemma":0.0014448217,"teacher_disagreement_score":0.003147077,"about_ca_system_score_codex":0.0008038794,"about_ca_system_score_gemma":0.00023820125,"threshold_uncertainty_score":0.010527968},"labels":[],"label_agreement":null},{"id":"W4406471500","doi":"10.1002/cac2.12661","title":"Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Dosing; Pembrolizumab; Medicine; Medical physics; Psychology; Pharmacology; Internal medicine; Pharmacokinetics; Cancer; Immunotherapy","score_opus":0.03932492012326258,"score_gpt":0.4011608327392284,"score_spread":0.3618359126159658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406471500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04468534,0.8624517,0.043810807,0.03374355,0.0012752159,0.00029842686,0.00080454786,0.0002310251,0.012699331],"genre_scores_gemma":[0.49091423,0.42872,0.049486164,0.019148063,0.0053861486,0.0008992243,0.0020485024,0.0003753094,0.0030223236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98910356,0.0056651984,0.001028574,0.0015908524,0.002370458,0.00024136844],"domain_scores_gemma":[0.9775056,0.01369209,0.003750059,0.00115104,0.0032777167,0.0006234786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02404026,0.00071432034,0.002603413,0.00094973773,0.00027711398,0.004604237,0.0022302351,0.002599919,0.0062453714],"category_scores_gemma":[0.036558773,0.00035731844,0.0013830549,0.0014916238,0.0016301839,0.0030746565,0.0010441944,0.003226699,0.0010007051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038538065,0.00076635624,0.005840306,0.0032660167,0.00071430416,0.00014849425,0.00025109705,0.006149216,0.0042734686,0.011526098,0.012793127,0.9504177],"study_design_scores_gemma":[0.0028911787,0.020437146,0.038095042,0.013990005,0.003905567,0.0029487824,0.0015505109,0.069023296,0.018994123,0.10426102,0.7232954,0.00060797273],"about_ca_topic_score_codex":0.0012630299,"about_ca_topic_score_gemma":0.0010438891,"teacher_disagreement_score":0.02404026,"about_ca_system_score_codex":0.0018698197,"about_ca_system_score_gemma":0.0026869054,"threshold_uncertainty_score":0.12713861},"labels":[],"label_agreement":null},{"id":"W4410905923","doi":"10.1002/cac2.70036","title":"Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Gemcitabine; Cancer; Medicine; Biology; Internal medicine; Phosphorylation; Signal transduction; Cell biology","score_opus":0.026813059557603505,"score_gpt":0.3202265771922991,"score_spread":0.2934135176346956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410905923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936575,0.0027347307,0.00144384,0.00020698698,0.0000742328,0.000072466326,0.0003257726,0.00020188306,0.001282549],"genre_scores_gemma":[0.99526125,0.0012887554,0.00089683465,0.000075154625,0.000014815542,0.00006511793,0.0005613155,0.000021707496,0.0018149872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998833,0.000014046434,0.000014711387,0.000019037041,0.000023948587,0.000045034834],"domain_scores_gemma":[0.99993265,0.000005956557,0.00001763108,0.000008425283,0.000010192591,0.0000251252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001690103,0.0003098096,0.00051332905,0.00026503464,0.00018191559,0.00029789255,0.00024095994,0.00022555824,0.001444372],"category_scores_gemma":[0.00010020331,0.00012093552,0.00039953974,0.00018352715,0.00024827366,0.00025613923,0.00021741069,0.0008631719,0.00028143293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002572029,0.00053147547,0.0011492901,0.00027417045,0.00005086499,0.00011584544,0.000044147826,0.00020125323,0.98317045,0.00019263716,0.000496166,0.011201675],"study_design_scores_gemma":[0.00048600545,0.005870174,0.009824496,0.000022068401,0.00014534342,0.00045928927,0.00011619481,0.0017067775,0.97389877,0.00015295326,0.007304247,0.000013736049],"about_ca_topic_score_codex":0.0006172295,"about_ca_topic_score_gemma":0.0016287124,"teacher_disagreement_score":0.001444372,"about_ca_system_score_codex":0.00031562673,"about_ca_system_score_gemma":0.0004951511,"threshold_uncertainty_score":0.00483191},"labels":[],"label_agreement":null},{"id":"W4413942153","doi":"10.1002/cac2.70058","title":"Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by <i>UGT1A1</i> status in patients with locally advanced rectal cancer: 5‐year update of the CinClare trial","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"Key Research and Development Program of Zhejiang Province; National Health Commission of the People's Republic of China; National Natural Science Foundation of China","keywords":"Capecitabine; Irinotecan; Colorectal cancer; Medicine; Oncology; Internal medicine; Chemoradiotherapy; Neoadjuvant therapy; Cancer","score_opus":0.009827375372114715,"score_gpt":0.29053532309810265,"score_spread":0.28070794772598795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413942153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84103876,0.13859272,0.001511526,0.0035003512,0.0012586479,0.0014760554,0.0037260812,0.00013535908,0.008760602],"genre_scores_gemma":[0.9594033,0.024431081,0.0021088792,0.00406134,0.0012381301,0.0014600736,0.005506699,0.000045014975,0.0017454617],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99781275,0.0013040802,0.0002471638,0.00023873609,0.00026822143,0.00012905624],"domain_scores_gemma":[0.99645495,0.0011513196,0.0011567982,0.00036076587,0.0003239002,0.0005522959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067051523,0.00065722945,0.002332517,0.0003501369,0.0003471434,0.0017302461,0.00082146213,0.00094613584,0.0016174158],"category_scores_gemma":[0.0041788653,0.00029114957,0.0031447606,0.0005754722,0.0005000755,0.0009275489,0.00047685168,0.0023996308,0.00024550076],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59962416,0.0064029777,0.05291518,0.007612739,0.031186678,0.00019730978,0.0003985727,0.0034853164,0.0057200654,0.0010242199,0.017694963,0.2737378],"study_design_scores_gemma":[0.57715255,0.15013535,0.15251866,0.0025697178,0.043679453,0.0007481936,0.00036411572,0.0046000825,0.0040316526,0.00159653,0.06232563,0.00027798855],"about_ca_topic_score_codex":0.000634376,"about_ca_topic_score_gemma":0.0019205249,"teacher_disagreement_score":0.0067051523,"about_ca_system_score_codex":0.0008835559,"about_ca_system_score_gemma":0.00076572085,"threshold_uncertainty_score":0.03546065},"labels":[],"label_agreement":null}]}